Sigma-Aldrich Continues to Expand Analytical Suite With Resource Technology Corporation Acquisition

ST. LOUIS, Jan. 31, 2011 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) announced today that it has acquired the assets of Resource Technology Corporation (RTC) of Laramie, Wyoming, an industry leader in analytical standards and certified reference materials. The acquisition of RTC's business complements the recently completed acquisition of Cerilliant Corporation, and further expands and strengthens Sigma-Aldrich's analytical chemistry offerings, a key goal in assisting the Company in delivering on its strategic sales growth plans. Terms of the purchase were not disclosed.

The RTC product offerings also complement the Company's well-regarded Supelco and Fluka brand analytical reagents, standards and separation consumables with the addition of its core expertise in design, development, characterization and packaging of analytical standards, matrix standards, certified reference materials and proficiency testing. With this acquisition, Sigma-Aldrich now serves a wide range of applications, including the fast-growing environmental and pharmaceutical sectors.

"The strong and innovative products offered by RTC bring new opportunities for expanding our business," commented Russel Gant, Vice President of the Analytical Research business for Sigma-Aldrich.  "Their experienced team, capabilities and customer contacts combine nicely with our breadth of product, high-quality portfolio, extensive scientific knowledge and global footprint. The RTC acquisition will allow Sigma-Aldrich to provide customers with an even broader range of specialized, analytical standards and services."

This is the second acquisition made by Sigma-Aldrich in recent weeks. In December 2010, the Company acquired Cerilliant Corporation, an industry leader in supplying high quality reference standards and materials that support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic and clinical toxicology markets.

Cautionary statement: The foregoing release contains forward-looking statements that can be identified by terminology such as "strengthens," "expands," "expects," or similar expressions, or by expressed or implied discussions regarding potential future revenues from products derived therefrom. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that the acquisition of the business of RTC will achieve any particular levels of revenue in the future. In particular, management's expectations regarding the acquisition of the RTC business could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; the Company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Company's assets and liabilities as recorded in its consolidated balance sheet, and other risks and factors referred to in Sigma-Aldrich's current Form 10-K on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sigma-Aldrich is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company committed to Enabling Science to Improve the Quality of Life. Its chemical and biochemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. More than one million scientists and technologists use its products. Sigma-Aldrich operates in 40 countries and has 7,900 employees providing excellent service worldwide. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.

Sigma-Aldrich is a trademark of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co.

SOURCE Sigma-Aldrich Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED